Radim Becvar
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 25, 2026
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database.
Journal: Journal of autoimmunity
Published: February 05, 2026
Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score.
Journal: Annals of the rheumatic diseases
Published: November 05, 2025
Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 27, 2025
Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study.
Journal: NPJ digital medicine
Published: April 23, 2025
CRTAC1: a novel indicator of lung involvement in SSc.
Journal: Rheumatology (Oxford, England)
Published: February 21, 2025
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133).
Journal: Annals of the rheumatic diseases
Published: February 03, 2025
Serum IL-40 is elevated in systemic sclerosis and is linked to disease activity, gastrointestinal involvement, immune regulation and fibrotic processes.
Journal: Arthritis research & therapy
Published: November 22, 2024
Oral Glucocorticoids for Skin Fibrosis in Early Diffuse Systemic Sclerosis: A Target Trial Emulation Study From the European Scleroderma Trials and Research Group Database.
Journal: Arthritis care & research
Published: July 10, 2024
Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: April 08, 2024
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review.
Journal: European journal of internal medicine
Published: December 31, 2023
Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650.
Journal: Biomedicines
Published: September 23, 2023
Last Updated: 09/26/2026